193 related articles for article (PubMed ID: 36821045)
21. Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics.
Qian X; Zhou C; Wang F; Lu X; Zhang Y; Chen L; Zeng M
Radiol Med; 2023 Mar; 128(3):274-288. PubMed ID: 36773271
[TBL] [Abstract][Full Text] [Related]
22. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases.
Xu Y; Ye F; Li L; Yang Y; Ouyang J; Zhou Y; Wang S; Xie L; Zhou J; Zhao H; Zhao X
Acad Radiol; 2023 Sep; 30(9):2010-2020. PubMed ID: 37414635
[TBL] [Abstract][Full Text] [Related]
23. Preoperative MRI features predicting very early recurrence of intrahepatic mass-forming cholangiocarcinoma after R0 resection: a comparison with the AJCC 8th edition staging system.
Chen S; Wan L; Zhao R; Peng W; Zou S; Zhang H
Abdom Radiol (NY); 2024 Jan; 49(1):21-33. PubMed ID: 37815613
[TBL] [Abstract][Full Text] [Related]
24. Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers.
Zhao L; Ma X; Liang M; Li D; Ma P; Wang S; Wu Z; Zhao X
Cancer Imaging; 2019 Jul; 19(1):49. PubMed ID: 31307551
[TBL] [Abstract][Full Text] [Related]
25. CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma.
Wakiya T; Ishido K; Kimura N; Nagase H; Kanda T; Ichiyama S; Soma K; Matsuzaka M; Sasaki Y; Kubota S; Fujita H; Sawano T; Umehara Y; Wakasa Y; Toyoki Y; Hakamada K
Sci Rep; 2022 May; 12(1):8428. PubMed ID: 35590089
[TBL] [Abstract][Full Text] [Related]
26. Integrating intratumoral and peritumoral features to predict tumor recurrence in intrahepatic cholangiocarcinoma.
Xu L; Wan Y; Luo C; Yang J; Yang P; Chen F; Wang J; Niu T
Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34096890
[TBL] [Abstract][Full Text] [Related]
27. CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Jiao CY; Zhang H; Ji GW; Xu Q; Lu M; Zhang B; Yang Y; Wang XH; Li XC
Eur Radiol; 2022 Dec; 32(12):8326-8338. PubMed ID: 35708837
[TBL] [Abstract][Full Text] [Related]
28. Radiomics-based model for predicting early recurrence of intrahepatic mass-forming cholangiocarcinoma after curative tumor resection.
Zhu Y; Mao Y; Chen J; Qiu Y; Guan Y; Wang Z; He J
Sci Rep; 2021 Sep; 11(1):18347. PubMed ID: 34526604
[TBL] [Abstract][Full Text] [Related]
29. Preoperative prediction of intrahepatic cholangiocarcinoma lymph node metastasis by means of machine learning: a multicenter study in China.
Huang T; Liu H; Lin Z; Kong J; Lin K; Lin Z; Chen Y; Lin Q; Zhou W; Li J; Li JT; Zeng Y
BMC Cancer; 2022 Aug; 22(1):931. PubMed ID: 36038816
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
[TBL] [Abstract][Full Text] [Related]
31. Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma.
Peng YT; Zhou CY; Lin P; Wen DY; Wang XD; Zhong XZ; Pan DH; Que Q; Li X; Chen L; He Y; Yang H
Acad Radiol; 2020 Jun; 27(6):785-797. PubMed ID: 31494003
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
[TBL] [Abstract][Full Text] [Related]
33. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
34. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
[TBL] [Abstract][Full Text] [Related]
35. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study: erratum.
Int J Surg; 2024 May; 110(5):3138. PubMed ID: 38748504
[No Abstract] [Full Text] [Related]
37. Multidetector computed tomography in the preoperative workup of hilar cholangiocarcinoma.
Kim HJ; Lee DH; Lim JW; Ko YT
Acta Radiol; 2009 Oct; 50(8):845-53. PubMed ID: 19639473
[TBL] [Abstract][Full Text] [Related]
38. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of Noninvasive MRI-Based Signature for Preoperative Prediction of Early Recurrence in Perihilar Cholangiocarcinoma.
Zhao J; Zhang W; Zhu YY; Zheng HY; Xu L; Zhang J; Liu SY; Li FY; Song B
J Magn Reson Imaging; 2022 Mar; 55(3):787-802. PubMed ID: 34296802
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of tumor vascularity on CT in resectable intrahepatic cholangiocarcinoma.
Park HM; Jang HY; Lee DE; Kang MJ; Han SS; Kim SW; Park SJ
HPB (Oxford); 2022 Mar; 24(3):359-369. PubMed ID: 34325966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
